| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc408585f6863d7865c90ab9a4632135 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0659
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0658 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 |
| filingDate |
1999-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28f89de3163d76d71a0f265aec72f6cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d185b9703ba454e7b640db086179bfc |
| publicationDate |
2001-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1113807-A2 |
| titleOfInvention |
Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction |
| abstract |
The present invention provides the use of muscle-derived myoblasts for the manufacture of a medicament for ameliorating stress urinary incontinence. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7887792-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685385-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7906110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8986671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9410124-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765120-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9352004-B2 |
| priorityDate |
1998-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |